BiotechTube

DS-8500a + Itraconazole

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics

Conditions

Pharmacokinetics

Trial Timeline

May 1, 2016 → Jun 1, 2016

NCT ID
NCT02790671

About DS-8500a + Itraconazole

DS-8500a + Itraconazole is a phase 1 stage product being developed by Daiichi Sankyo for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT02790671. Target conditions include Pharmacokinetics.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02790671Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics

See all competitors
ProductCompanyStageHype Score
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
15
GP40221 + ozempicGEROPHARMPhase 1
25
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
25
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
15
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
33
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-8500aDaiichi SankyoPhase 1
33
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
33
tolterodine + mirabegronAstellas PharmaApproved
85
ASP3652Astellas PharmaPhase 1
33
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
33
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
33
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
33
mirabegron + metoprololAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + DocetaxelAstellas PharmaPhase 2
52
Isavuconazole + Repaglinide + CaffeineAstellas PharmaPhase 1
33
mirabegron + rifampinAstellas PharmaPhase 1
33

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85